If the rash spreads or you have hives or facial swelling, contact your provider immediately
doi: 10.1016/j.jalz.2018.08.005 67 VogtN
Food and Drug Administration (FDA) approved tirzepatide for treating type 2 diabetes in 2022
This work was financially supported by the Research Vice-Chancellor, Nutrition Research Center, Tabriz University of Medical Sciences (Grant number: 59360), and Iran National Science Foundation (INSF). Ethics declarations Ethics Approval The study was performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments
This includes being consistent with the timing and frequency of Tirzepatide injections, as well as maintaining a healthy lifestyle
(PubMed) Labay V, Raz T, Baron D, et al